Molecular biology of HBV-related hepatocellular carcinoma

Chronic Hepatitis B and C: Basic Science to Clinical Applications

Volumn , Issue , 2012, Pages 99-131

  Hodgson, Amanda J ^a   Slagle, Betty L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84986556283     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789814299794_0004     Document Type: Chapter

References (56)

1. Beasley RP, Hwang LY, Lin CC, Chien CS. (1981) Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet 2: 1129-1133.
2. Butel JS. (2000) Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease. Carcin 21: 405-426.
3. Fattovich G, Bortolotti F, Donato F. (2008) Natural history of chronic hepatitis B: Special emphasis on disease progression and prognostic factors. J Hepatol 48: 335-352.
4. Butel JS, Lee T-H, Slagle BL. (1996) Is the DNA repair system involved in hepatitis-B-virus-mediated hepatocellular carcinogenesis? Trends Microbiol 4: 119-124.
5. Wieland S, Thimme R, Purcell RH, Chisari FV. (2004) Genomic analysis of the host response to hepatitis B virus infection. Proc Natl Acad Sci USA 101: 6669-6674.
6. Chang JJ, Lewin SR. (2007) Immunopathogenesis of hepatitis B virus infection. Immunol Cell Biol 85: 16-23.
7. Nakamoto Y, Guidotti LG, Kuhlen CV, et al. (1998) Immune pathogenesis of hepatocellular carcinoma. J Exp Med 188: 341-350.
8. Bouchard MJ, Schneider RJ. (2004) The enigmatic X gene of hepatitis B virus. J Virol 78: 12725-12734.
9. Terradillos O, Billet O, Renard CA, et al. (1997) The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 14: 395-404.
10. Madden CR, Finegold MJ, Slagle BL. (2001) Hepatitis B virus X protein acts as a tumor promoter in the development of diethylnitrosamine-induced preneoplastic lesions. J Virol 75: 3851-3858.
11. Loyer P, Cariou S, Glaise D, et al. (1996) Growth factor dependence of progression through G1 and S phases of adult rat hepatocytes in vitro. J Biol Chem 271: 11484-11492.
12. Hodgson AJ, Keasler VV, Slagle BL. (2008) Premature cell cycle entry induced by hepatitis B virus regulatory HBx protein during compensatory liver regeneration. Canc Res 68: 10341-10348.
13. Tralhao JG, Roudier J, Morosan S, et al. (2002) Paracrine in vivo inhibitory effects of hepatitis B virus X protein (HBx) on liver cell proliferation: An alternative mechanism of HBx-related pathogenesis. Proc Natl Acad Sci USA 99: 6991-6996.
14. Wu BK, Li CC, Chen HJ, et al. (2006) Blocking of G1/S transition and cell death in the regenerating liver of Hepatitis B virus X protein transgenic mice. Biochem Biophys Res Commun 340: 916-928.
15. Guidotti LG, Matzke B, Chisari FV. (1997) Hepatitis B virus replication is cell cycle independent during liver regeneration in transgenic mice. J Virol 71: 4804-4808.
16. Dong Z, Zhang J, Sun R, et al. (2007) Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice. Hepatology 45: 1400-1412.
17. Petersen J, Dandri M, Bürkle A, et al. (1997) Increase in the frequency of hepadnavirus DNA integrations by oxidative DNA damage and inhibition of DNA repair. J Virol 71: 5455-5463.
18. Wei Y, Fourel G, Ponzetto A, et al. (1992) Hepadnavirus integration: mechanisms of activation of the N-myc2 retrotransposon in woodchuck liver tumors. J Virol 66: 5265-5276.
19. Paterlini-Brechot P, Saigo K, Murakami Y, et al. (2003) Hepatitis B virus-related insertional mutagenesis occurs frequently in human liver cancers and recurrently targets human telomerase gene. Oncogene 22: 3911-3916.
20. Slagle BL, Lee TH, Butel JS. (1992) Hepatitis B virus and hepatocellular carcinoma. [Review]. Prog Med Virol 39: 167-203.
21. Chisari FV, Ferrari C. (1995) Hepatitis B virus immunopathogenesis. Annual Review of Immunology 13: 29-60.
22. Hildt E, Hofschneider PH. (1998) The PreS2 activators of the hepatitis B virus: Activators of tumour promoter pathways. Recent Results Cancer Res 154: 315-329.
23. Hildt E, Munz B, Saher G, et al. (2002) The PresS2 activator MHBst of hepatitis B virus activates c-raf-1/Erk2 signaling in transgenic mice. EMBO 21: 525-535.
24. Schluter V, Meyer M, Hofschneider PH, et al. (1994) Integrated hepatitis B virus X and 3' truncated preS/S sequences derived from human hepatomas encode functionally active transactivators. Oncogene 9: 3335-3344.
25. Zoulim F, Saputelli J, Seeger C. (1994) Woodchuck hepatitis virus X protein is required for viral infection in vivo. J Virol 68: 2026-2030.
26. Keasler VV, Hodgson AJ, Madden CR, Slagle BL. (2007) Enhancement of hepatitis B virus replication by the regulatory X protein in vitro and in vivo. J Virol 81: 2656-2662.
27. Bouchard MJ, Wang L-H, Schneider RJ. (2002) Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 294: 2376-2378.
28. Takada S, Shirakata Y, Kaneniwa N, Koike K. (1999) Association of hepatitis B virus X protein with mitochondria causes mitochondrial aggregation at the nuclear periphery, leading to cell death. Oncogene 18: 6965-6973.
29. Teodoro JG, Branton PE. (1997) Minireview: regulation of apoptosis by viral gene products. J Virol 71: 1739-1746.
30. Pollicino T, Terradillos O, Lecoeur H, et al. (1998) Pro-apoptotic effect of the hepatitis B virus X gene. Biomed Pharmacother 52: 363-368.
31. Terradillos O, Pollicino T, Lecoeur H, et al. (1998) p53-independent apoptotic effects of the hepatitis B virus HBx protein in vivo and in vitro. Oncogene 17: 2115-2123.
32. Madden CR, Finegold MJ, Slagle BL. (2000) Expression of hepatitis B virus X protein does not alter the accumulation of spontaneous mutations in transgenic mice. J Virol 74: 5266-5272.
33. Koike K, Moriya K, Iino S, et al. (1994) High-level expression of hepatitis B virus HBx gene and hepatocarcinogenesis in transgenic mice. Hepatology 19: 810-819.
34. Lee T-H, Elledge SJ, Butel JS. (1995) Hepatitis B virus X protein interacts with a probable cellular DNA repair protein. J Virol 69: 1107-1114.
35. Becker SA, Lee TH, Butel JS, Slagle BL. (1998) Hepatitis B virus X protein interferes with cellular DNA repair. J Virol 72: 266-272.
36. Melegari M, Scaglioni PP, Wands JR. (1998) Cloning and characterization of a novel hepatitis B virus X binding protein that inhibits viral replication. J Virol 72: 1737-1743.
37. Fujii R, Zhu CJ, Wen YF, et al. (2006) HBXIP, cellular target of hepatitis B virus oncoprotein, is a regulator of centrosome dynamics and cytokinesis. Cancer Res 66: 9099-9107.
38. Park IY, Sohn BH, Yu E, et al. (2007) Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology 132: 1476-1494.
39. Kim C-M, Koike K, Saito I, et al. (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351: 317-320.
40. Gottwein E, Cullen BR. (2008) Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbe 3: 375-387.
41. Shi XB, Tepper CG, deVere White RW. (2008) Cancerous miRNAs and their regulation. Cell Cycle 7: 1529-1538.
42. Ladeiro Y, Couchy G, Balabaud C, et al. (2008) MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations. Hepatology 47: 1955-1963.
43. Connolly E, Melegari M, Landgraf P, et al. (2008) Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype. Am J Pathol 173: 856-864.
44. Meng F, Henson R, Wehbe-Janek H, et al. (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133: 647-658.
45. Wong QW, Lung RW, Law PT, et al. (2008) MicroRNA-223 is commonly repressed in hepatocellular carcinoma and potentiates expression of Stathmin1. Gastroenterology 135: 257-269.
46. Jin WB, Wu FL, Kong D, Guo AG. (2007) HBV-encoded microRNA candidate and its target. Comput Biol Chem 31: 124-126.
47. Buendia MA. (2000) Genetics of hepatocellular carcinoma. Seminars in Cancer Biology 10: 185-200.
48. Martin-Lluesma S, Schaeffer C, Robert EI, et al. (2008) Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1. Hepatology 48: 1467-1476.
49. Tischoff I, Tannapfe A. (2008) DNA methylation in hepatocellular carcinoma. World J Gastroenterol 14: 1741-1748.
50. Donato F, Boffetta P, Puoti M. (1998) A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma. Int J Cancer 75: 347-354.
51. Keasler VV, Lerat H, Madden CR, et al. (2006) Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein. Virology 347: 466-475.
52. Madden CR, Finegold MJ, Slagle BL. (2002) Altered DNA Mutation Spectrum in Aflatoxin B1-Treated Transgenic Mice that Express the Hepatitis B Virus X Protein. J Virol 76: 11770-11774.
53. Chang MH, Chen CJ, Lai MS, et al. (1997) Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. N Engl J Med 336: 1855-1859.
54. Bohne F, Protzer U. (2007) Adoptive T-cell therapy as a therapeutic option for chronic hepatitis B. J Viral Hepat 14(Suppl 1): 45-50.
55. Arbuthnot P, Thompson LJ. (2008) Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma. World J Gastroenterol 14: 1670-1681.
56. Chen Y, Cheng G, Mahato RI. (2008) RNAi for treating hepatitis B viral infection. Pharm Res 25: 72-86.